Finally, a helpful intervention in the ‘overdiagnosis’ wars. But where’s the money to answer this tragedy? | John Harris - The Guardian
This story deserves to be shared
Send it to someone who'd care, or post it on your networks.
Back in late 2025, when Keir Starmer’s grip on the Labour party was loosening and Reform UK was still in its pomp, the then health secretary, Wes Streeting, commissioned what the government called its “Independent review into prevalence and support for mental health conditions, ADHD and autism”. Here, it seemed, was not just an inquiry into England’s ever-extending waiting lists for the diagnosis of mental illness and neurodevelopmental conditions, and the dire lack of support for people who experience one or both of them. The review would also dovetail with two other huge issues: mounting claims of “overdiagnosis”, which Streeting had appeared to partly endorse, and the government’s drive for the reform of so-called welfare. An apparently well-briefed piece in the Times seemed to speak volumes: work led by the renowned psychologist Peter Fonagy, it said, was commencing just “as Labour seeks a fresh crackdown on welfare spending” amid diagnoses “which have become the most common reason for a sickness benefit claim”.
This article is an excerpt. To read the full content, visit the original source. The Guardian
Related articles
The Guardian view on mental health: overdiagnosis is not the problem facing young people | Editorial - The Guardian
Perhaps the single most important finding of the independent review into mental health, ADHD and autism in England, published last Friday, is that mental distress across the population, and particularly young people, has substantially worsened. Its chair, Prof Peter Fonagy, told the BBC that the former health secretary Wes Streeting had been “completely wrong” to suggest that conditions and disorders were being overdiagnosed. Mr Streeting acknowledged his mistake. But some rightwing politicians and commentators have leapt on the notion that medicalisation of ordinary states of mind is behind the huge rise in young people seeking help. This review should bury that idea. Instead, this should be a moment to face facts. First, that the rises in psychological distress, and the need for support with neurodevelopmental differences, are real and tied to social changes. Second, that current services are not up to what is being asked of them. Fifteen years after the phrase “parity of esteem” gained prominence – the idea being that people with mental ill health have equivalent entitlements to those with physical illnesses – it is a long way from being realised.
Continuous glucose monitors help type 2 diabetes patients spend 5 more hours a day in healthy blood sugar range - Medical Xpress
Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.
Wearing headphones during surgery may reduce nausea and vomiting afterward - Medical Xpress
Patients who wore noise-canceling headphones during minimally invasive gynecological surgery were significantly less likely to experience postoperative nausea and vomiting (PONV), suggest findings from a randomized clinical trial presented at the Anesthesiology 2026 annual meeting.
Kefah Mokbel: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? - Oncodaily
“Beyond Detecting Cancer Recurrence: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? An exciting new study published in The Oncologist highlights the clinical potential of Signatera Genome, a whole-genome sequencing (WGS)-based, tumor-informed circulating tumor DNA (ctDNA) assay, not only for detecting molecular residual disease (MRD), but also for potentially informing adjuvant treatment decisions.
0 comments
No comments yet. Be the first to share your thoughts!